QDEL as of Nov 2 · 04:03 ET
QDELNasdaqIn Vitro & In Vivo Diagnostic Substances
QuidelOrtho Corp · Brief
Next report
1 day
Nov 3 · after closeconfirmedQ3 FY26
Expected move
Inputs3 of 6≥ implied
- avg implied
- ±13.5%
- avg realized
- ±15.4%
Nov 7 '24—▲+12.61%—
Feb 12 '25±12.3%▲+4.28%×0.35
May 7 '25±16.6%▲+41.04%×2.47
Aug 5 '25±10.5%▼−1.01%×0.10
Nov 5 '25±13.9%▼−22.32%×1.61
Feb 11 '26±11.5%▼−17.59%×1.53
Q1 FY26±16.4%▼−6.00%×0.37
Q2 FY26—▼−24.72%—
quarterimplied−45%0+45%realized×
Q2 FY26—▼−24.72%—
Q1 FY26±16.4%▼−6.00%×0.37
Feb '26±11.5%▼−17.59%×1.53
Nov '25±13.9%▼−22.32%×1.61
Aug '25±10.5%▼−1.01%×0.10
May '25±16.6%▲+41.04%×2.47
2 older reports
Feb '25±12.3%▲+4.28%×0.35
Nov '24—▲+12.61%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 3 report · confirmedBull2 of 3
Bear2 of 3
AI captions · Oct 26 '26once per report · top 2 per case
Linked exposure
QDEL report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.